This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult …

Advanced Solid TumorsPlatinum Resistant Ovarian CancerFallopian Tube Cancer+5 more

~Estimated

~$10 – $8,750

NextCure, Inc.NCT06792552

Phase 1

A Phase I/II Study of Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

Background: Kidney cancer is the 12th leading cause of cancer-related death in the United States. Some kidney tumors do not respond well to current treatments…

Advanced Clear Cell Renal Carcinoma (Ccrcc)Papillary Renal Cell Carcinoma (Prcc)

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05665361